G1 Therapeutics, Inc. (GTHX) SEC filings
GTHX SEC filings moved a median of +3.64% by the close. GTHX SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the GTHX overview →
22 measured GTHX SEC filing events.
Where these GTHX SEC filings landedvs 19 measured GTHX SEC filing reactions
| Middle 50% of GTHX SEC filing reactions | -0.07% to +16.80% |
|---|---|
| Median reaction (to close) | +3.64% |
| Measured reactions | 19 |
Point-in-time · zero look-ahead
Half of the 19 GTHX SEC filing events with a measured close landed between -0.07% and +16.80%; 74% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 15-12G G1 Therapeutics, Inc. | SEC filing · Form 15-12G | — | — | |
| Form 8-K G1 Therapeutics, Inc. For: Sep 18 | SEC filing · Form 8-K | — | — | |
| Form S-8 POS G1 Therapeutics, Inc. | SEC filing · Form S-8 | — | — | |
| Form 10-Q G1 Therapeutics, Inc. For: Jun 30 | SEC filing · Form 10-Q | +0.07% | +0.14% | |
| Form 8-K G1 Therapeutics, Inc. For: Aug 08 | SEC filing · Form 8-K | +0.25% | +0.57% | |
| Form 8-K G1 Therapeutics, Inc. For: Aug 06 | SEC filing · Form 8-K | -0.21% | -0.28% | |
| Form 8-K G1 Therapeutics, Inc. For: Jun 24 | SEC filing · Form 8-K | +12.33% | +52.05% | |
| Form 8-K G1 Therapeutics, Inc. For: Jun 13 | SEC filing · Form 8-K | +0.00% | -4.30% | |
| Form 10-Q G1 Therapeutics, Inc. For: Mar 31 | SEC filing · Form 10-Q | +2.65% | +6.99% | |
| Form 8-K G1 Therapeutics, Inc. For: May 01 | SEC filing · Form 8-K | +5.68% | +17.33% | |
| Form ARS G1 Therapeutics, Inc. For: Dec 31 | SEC filing · Form ARS | +0.91% | +3.64% | |
| Form DEF 14A G1 Therapeutics, Inc. For: Jun 13 | SEC filing · Form DEF | +0.91% | +3.64% | |
| Form DEFA14A G1 Therapeutics, Inc. | SEC filing · Form DEFA14A | +0.91% | +3.64% | |
| Form PRE 14A G1 Therapeutics, Inc. For: Jun 13 | SEC filing · Form PRE | -1.74% | -6.51% | |
| Form 8-K G1 Therapeutics, Inc. For: Mar 21 | SEC filing · Form 8-K | +1.51% | +4.54% | |
| Form 10-K G1 Therapeutics, Inc. For: Dec 31 | SEC filing · Form 10-K | +2.50% | +3.75% | |
| Form 8-K G1 Therapeutics, Inc. For: Feb 28 | SEC filing · Form 8-K | +5.75% | +32.14% | |
| Form 8-K G1 Therapeutics, Inc. For: Feb 12 | SEC filing · Form 8-K | -4.22% | -15.66% | |
| Form 8-K G1 Therapeutics, Inc. For: Jan 08 | SEC filing · Form 8-K | +8.07% | +16.27% | |
| Form 10-Q G1 Therapeutics, Inc. For: Sep 30 | SEC filing · Form 10-Q | +3.03% | +23.48% | |
| Form 8-K G1 Therapeutics, Inc. For: Nov 01 | SEC filing · Form 8-K | +1.85% | -0.74% | |
| Form S-8 G1 Therapeutics, Inc. | SEC filing · Form S-8 | +3.03% | +23.48% |
Keep exploring
More GTHX: earnings → · analyst actions → · GTHX overview →
Other Healthcare names and their SEC filings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Redhill Biopharma Ltd. - American Depositary Shares (RDHL) | 143 | -0.50% | 39% |
| Alimera Sciences, Inc. (ALIM) | 142 | 0.00% | 42% |
| InflaRx N.V. (IFRX) | 142 | 0.00% | 48% |
| Oncocyte Corporation (OCX) | 141 | 0.00% | 47% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its SEC filings — that is what the link opens.